国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
聚乙二醇干扰素α-2a注射液不良反应报告分析
Analysis of the Reports of Adverse Drug Reactions Induced by PEG interferon Alfa-2a Injection
  
DOI:
中文关键词:  聚乙二醇干扰素α-2a  药品不良反应  报告  合理用药
英文关键词:PEG interferon alfa-2a  Adverse drug reaction  Report  Rational drug use
基金项目:
作者单位
韩丹 第二军医大学药事管理教研室(上海 200433)。 
代菲 第二军医大学药事管理教研室(上海 200433)。 
储文功 第二军医大学药事管理教研室(上海 200433)。 
摘要点击次数: 1040
全文下载次数: 1119
中文摘要:
      摘 要 目的:探讨聚乙二醇干扰素α 2a注射液不良反应发生的特点及相关因素,为临床安全用药提供参考。方法:收集某省药品不良反应监测中心2004~2011年自发呈报系统上报的1 606例聚乙二醇干扰素α-2a注射液的不良反应(ADR)报告,对ADR所涉及的患者年龄、性别,以及ADR年份、类型、结果、临床表现等进行统计分析。结果:1 606例报告中,男883例,女723例,30~60岁患者最多(72.6%);发生严重不良反应243例,新的严重ADR 86例;临床表现以血液系统损害为主占59.95%,其次为肝胆系统损害占10.76%。结论:临床在运用聚乙二醇干扰素α-2a治疗丙肝的过程中,应密切观察其ADR,制定周密的护理计划,积极干预和防治,以有效减少和防止ADR发生。
英文摘要:
      ABSTRACT Objective:To probe into the characteristics of adverse drug reactions(ADR) caused by PEG-interferon alfa-2a injection to provide some rational clinical guidance. Methods:1606 reports of adverse reactions caused by PEG-interferon alfa-2a injection were collected from January 2004 to December 2011 and statistically analyzed in respect of patients' sex and age, involved type, years, result, clinical manifestations, etc.Results:883 of the 1606 cases were male cases,723 were female cases, and 72.6%were the adults at the age of 30 to 60. The incidence rate of severe ADR were 243 cases, and new and severe ADR were 86 cases. The blood system was the main lesion in ADR cases (59.95%), and the second was liver and gall system(10.76%).Conclusion:The corresponding adverse reactions should be closely observed during the clinical use of PEG interferon alfa 2a in the treatment of hepatitis C. The occurrence of adverse reactions could be effectively reduced and prevented by making a careful nursing plan and conducting an active intervention and control.
查看全文  查看/发表评论  下载PDF阅读器
关闭